Explore how authorized generics disrupt pharmaceutical competition. Learn about their impact on patent litigation, FTC regulations, and the Hatch-Waxman Act.
VIEW MOREAfter the first generic enters the market, a cascade of competitors follows, triggering steep price drops and supply shortages. Learn how patent rules, authorized generics, and manufacturing bottlenecks shape the chaotic race to sell the same drug.
VIEW MORE